{"id":"https://openalex.org/W4415940619","doi":"https://doi.org/10.1016/j.annonc.2025.08.2331","title":"1704eTiP SUPRAME: A phase III trial evaluating IMA203 T-cell receptor (TCR) T-cell therapy vs investigator\u2019s choice in previously treated advanced cutaneous melanoma","display_name":"1704eTiP SUPRAME: A phase III trial evaluating IMA203 T-cell receptor (TCR) T-cell therapy vs investigator\u2019s choice in previously treated advanced cutaneous melanoma","publication_year":2025,"publication_date":"2025-09-01","ids":{"openalex":"https://openalex.org/W4415940619","doi":"https://doi.org/10.1016/j.annonc.2025.08.2331"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2025.08.2331","doi":"https://doi.org/10.1016/j.annonc.2025.08.2331","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2025.08.2331","pdf_url":"https://www.annalsofoncology.org/article/S0923-7534(25)03251-X/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.annalsofoncology.org/article/S0923-7534(25)03251-X/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034365278","display_name":"Dirk Schadendorf","orcid":"https://orcid.org/0000-0003-3524-7858","observed_orcids":["https://orcid.org/0000-0003-3524-7858"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Schadendorf","raw_affiliation_strings":["Department of Dermatology - Hautklinik, WTZ - Westdeutsches Tumorzentrum Essen, Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology - Hautklinik, WTZ - Westdeutsches Tumorzentrum Essen, Essen, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077044390","display_name":"W. Alsdorf","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108711","display_name":"University Medical Center Hamburg-Eppendorf","ror":"https://ror.org/01zgy1s35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I159176309","https://openalex.org/I4210108711"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"W. Alsdorf","raw_affiliation_strings":["Medical Clinic/Oncology Study Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Clinic/Oncology Study Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I4210108711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001132894","display_name":"R. Amaria","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Amaria","raw_affiliation_strings":["Melanoma Medical Oncology Department, The MD Anderson Cancer Center, Houston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melanoma Medical Oncology Department, The MD Anderson Cancer Center, Houston, United States of America","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071144743","display_name":"Allison Betof Warner","orcid":"https://orcid.org/0000-0001-6422-2997","observed_orcids":["https://orcid.org/0000-0001-6422-2997"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Betof Warner","raw_affiliation_strings":["Medicine Department, Stanford University School of Medicine, Stanford, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine Department, Stanford University School of Medicine, Stanford, United States of America","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031749009","display_name":"Tobias A.W. Holderried","orcid":"https://orcid.org/0000-0002-2474-523X","observed_orcids":["https://orcid.org/0000-0002-2474-523X"]},"institutions":[{"id":"https://openalex.org/I2799391451","display_name":"University Hospital Bonn","ror":"https://ror.org/01xnwqx93","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799391451"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"T. Holderried","raw_affiliation_strings":["Department of Hematology, Oncology, Immuno-Oncology, Stem Cell Transplantation, University Hospital Bonn, Bonn, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Oncology, Immuno-Oncology, Stem Cell Transplantation, University Hospital Bonn, Bonn, Germany","institution_ids":["https://openalex.org/I2799391451"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089816329","display_name":"Antonia Busse","orcid":"https://orcid.org/0000-0002-3470-6947","observed_orcids":["https://orcid.org/0000-0002-3470-6947"]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"A. Busse","raw_affiliation_strings":["Medizinische Klinik III, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medizinische Klinik III, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015140027","display_name":"Christoffer Gebhardt","orcid":"https://orcid.org/0000-0001-7090-9584","observed_orcids":["https://orcid.org/0000-0001-7090-9584"]},"institutions":[{"id":"https://openalex.org/I4210108711","display_name":"University Medical Center Hamburg-Eppendorf","ror":"https://ror.org/01zgy1s35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I159176309","https://openalex.org/I4210108711"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"C. Gebhardt","raw_affiliation_strings":["Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I4210108711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017136846","display_name":"John B.A.G. Haanen","orcid":"https://orcid.org/0000-0001-5884-7704","observed_orcids":["https://orcid.org/0000-0001-5884-7704"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J.B.A.G. Haanen","raw_affiliation_strings":["Department of Medical Oncology, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5134019330","display_name":"J.C. Hassel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111460","display_name":"National Center for Tumor Diseases","ror":"https://ror.org/01txwsw02","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529","https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210111460"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"J.C. Hassel","raw_affiliation_strings":["Section of DermatoOncology, NCT - Nationales Zentrum f\u00fcr Tumorerkrankungen, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of DermatoOncology, NCT - Nationales Zentrum f\u00fcr Tumorerkrankungen, Heidelberg, Germany","institution_ids":["https://openalex.org/I4210111460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010248442","display_name":"S. Klobuch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"S. Klobuch","raw_affiliation_strings":["Medical oncology, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical oncology, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100713900","display_name":"Caroline Robert","orcid":"https://orcid.org/0000-0002-9493-0238","observed_orcids":["https://orcid.org/0000-0002-9493-0238"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Robert","raw_affiliation_strings":["Dermatology Department, Institut Gustave Roussy, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Department, Institut Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034434819","display_name":"Martin Wermke","orcid":"https://orcid.org/0000-0002-4844-4087","observed_orcids":["https://orcid.org/0000-0002-4844-4087"]},"institutions":[{"id":"https://openalex.org/I78650965","display_name":"Technische Universit\u00e4t Dresden","ror":"https://ror.org/042aqky30","country_code":"DE","type":"education","lineage":["https://openalex.org/I78650965"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. Wermke","raw_affiliation_strings":["Early Clinical Trial Dept., Dresden University, Dresden, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Early Clinical Trial Dept., Dresden University, Dresden, Germany","institution_ids":["https://openalex.org/I78650965"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017038082","display_name":"Susanna C. DeVane","orcid":"https://orcid.org/0000-0002-4941-8956","observed_orcids":["https://orcid.org/0000-0002-4941-8956"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S.C. DeVane","raw_affiliation_strings":["Clinical Sciences, Immatics US., Inc., Houston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Sciences, Immatics US., Inc., Houston, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043902981","display_name":"Silvana Hengler","orcid":"https://orcid.org/0000-0001-6973-0800","observed_orcids":["https://orcid.org/0000-0001-6973-0800"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"S. Hengler","raw_affiliation_strings":["Translational Science, Immatics Biotechnologies GmbH, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Science, Immatics Biotechnologies GmbH, Munich, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. Krishna","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Krishna","raw_affiliation_strings":["Clinical Development, Immatics US., Inc., Houston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Immatics US., Inc., Houston, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091554806","display_name":"Andrea Mayer-Mokler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"A. Mayer-Mokler","raw_affiliation_strings":["Clinical Development Department, Immatics Biotechnologies GmbH, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development Department, Immatics Biotechnologies GmbH, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103182824","display_name":"Dmitry Pankov","orcid":"https://orcid.org/0000-0002-2262-9294","observed_orcids":["https://orcid.org/0000-0002-2262-9294","https://orcid.org/0009-0000-5562-7925"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Pankov","raw_affiliation_strings":["Clinical Development, Immatics US., Inc., Houston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Immatics US., Inc., Houston, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036257821","display_name":"Cedrik Michael Britten","orcid":"https://orcid.org/0000-0003-3424-8760","observed_orcids":["https://orcid.org/0000-0003-3424-8760"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"C. Britten","raw_affiliation_strings":["Medical, Immatics Biotechnologies GmbH, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical, Immatics Biotechnologies GmbH, Munich, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063337705","display_name":"Jason J. Luke","orcid":"https://orcid.org/0000-0002-1182-4908","observed_orcids":["https://orcid.org/0000-0002-1182-4908"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.J. Luke","raw_affiliation_strings":["Malignant Hematology and Medical Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology and Medical Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, United States of America","institution_ids":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.33222087,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":null,"first_page":"S939","last_page":"S939"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5913000106811523,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5913000106811523,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.22010000050067902,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.08030000329017639,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tcr-t-cell-therapy","display_name":"TCR-T cell therapy","score":0.824999988079071},{"id":"https://openalex.org/keywords/prame","display_name":"PRAME","score":0.7200000286102295},{"id":"https://openalex.org/keywords/cutaneous-melanoma","display_name":"cutaneous melanoma","score":0.8619999885559082},{"id":"https://openalex.org/keywords/autologous-t-cells","display_name":"autologous T cells","score":0.8289999961853027},{"id":"https://openalex.org/keywords/hla-presented-peptides","display_name":"HLA-presented peptides","score":0.722000002861023},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.5389999747276306},{"id":"https://openalex.org/keywords/anti-tumor-response","display_name":"anti-tumor response","score":0.5210000276565552},{"id":"https://openalex.org/keywords/durable-response","display_name":"durable response","score":0.3919999897480011}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9714000225067139},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5611000061035156},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5307000279426575},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.3847000002861023},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.37439998984336853},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.3682999908924103},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3555999994277954},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3352000117301941},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.27250000834465027},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.22220000624656677}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2025.08.2331","doi":"https://doi.org/10.1016/j.annonc.2025.08.2331","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2025.08.2331","pdf_url":"https://www.annalsofoncology.org/article/S0923-7534(25)03251-X/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2025.08.2331","doi":"https://doi.org/10.1016/j.annonc.2025.08.2331","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2025.08.2331","pdf_url":"https://www.annalsofoncology.org/article/S0923-7534(25)03251-X/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"},{"id":"https://openalex.org/F4320308982","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421"},{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"},{"id":"https://openalex.org/F4320312570","display_name":"Jazz Pharmaceuticals","ror":"https://ror.org/055mhsv54"},{"id":"https://openalex.org/F4320312902","display_name":"Society for Immunotherapy of Cancer","ror":"https://ror.org/0481e3r23"},{"id":"https://openalex.org/F4320314128","display_name":"Les Laboratories Pierre Fabre","ror":"https://ror.org/04hdhz511"},{"id":"https://openalex.org/F4320316932","display_name":"Mersana Therapeutics","ror":"https://ror.org/05jyg6z06"},{"id":"https://openalex.org/F4320317544","display_name":"Incyte","ror":"https://ror.org/00cvzzg84"},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320327470","display_name":"Swedish Orphan Biovitrum","ror":"https://ror.org/04asvbz37"},{"id":"https://openalex.org/F4320327811","display_name":"PharmaMar","ror":"https://ror.org/02h694m69"},{"id":"https://openalex.org/F4320328070","display_name":"Sun Pharma","ror":"https://ror.org/04vnqkx80"},{"id":"https://openalex.org/F4320328455","display_name":"Ipsen","ror":"https://ror.org/00d801g55"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320332200","display_name":"EMD Serono","ror":"https://ror.org/027zrs220"},{"id":"https://openalex.org/F4320338262","display_name":"Daiichi Sankyo Europe","ror":"https://ror.org/01qhj1g70"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4415940619.pdf","grobid_xml":"https://content.openalex.org/works/W4415940619.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4410809759","https://openalex.org/W7103976921","https://openalex.org/W4410802615","https://openalex.org/W4409279341","https://openalex.org/W4415899334","https://openalex.org/W7154947898","https://openalex.org/W7162500941","https://openalex.org/W4404053191","https://openalex.org/W4389241704","https://openalex.org/W7117320086"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2025-11-06T00:00:00"}